How to Value a Veterinary Diagnostic Equipment Distributor in 2026

Veterinary diagnostics distribution sits at a fascinating intersection of healthcare, equipment sales, and recurring service revenue. I've advised on several transactions in this space, and the valuation dynamics surprise most owners. Your business isn't really about selling equipment — the equipment sale is just the mechanism for building an installed base that generates service contracts, consumable revenue, and customer lock-in for years.

Well-run veterinary diagnostic equipment distributors trade at 4-7x EBITDA, with the range driven by the quality of your manufacturer relationships, the size and stickiness of your installed base, and how much of your revenue is recurring versus one-time equipment sales.

The Manufacturer Relationship Is Everything

In veterinary diagnostics, the market is dominated by a handful of manufacturers: IDEXX Laboratories (roughly 55-60% market share in reference lab and in-clinic diagnostics), Zoetis/Abaxis (point-of-care analyzers), Heska, and a few smaller players. Your distribution agreement with one or more of these companies is the foundation of your business value.

Exclusive territory agreementsare the gold standard. If you hold an exclusive right to sell and service IDEXX Catalyst or ProCyte analyzers in a defined geography — say, a 200-mile radius covering 400 veterinary practices — that territorial exclusivity is a major value driver. It creates a defensible moat that competitors can't easily penetrate. Distributors with exclusive territories trade at 6-7x EBITDA.

Non-exclusive authorized dealerarrangements are less valuable because you're competing against other dealers and potentially the manufacturer's own direct sales team. These firms still have value — they've built relationships and local expertise — but the lack of territorial protection caps the multiple at 4-5x EBITDA.

The critical due diligence question buyers will ask: Is your distribution agreement assignable?If the manufacturer has to consent to a transfer, and they could refuse or renegotiate terms, that creates transaction risk. I've seen deals where the manufacturer used the ownership change as leverage to modify territory boundaries or commission structures. Get clarity on assignability early in your sale process.

Installed Base: The Real Asset

An in-clinic chemistry analyzer costs $15,000-$45,000 for the hardware. But the real economics are in what follows: consumable reagent cartridges ($3-8 per test, with an active practice running 15-30 tests per day), annual service contracts ($2,000-$5,000 per instrument), and software subscriptions for cloud-based results management.

A distributor with 500 installed instruments across 300 veterinary practices isn't a $15M equipment business. It's a business with $1.5-2.5M in annual recurring consumable and service revenue, plus $2-4M in equipment sales. The recurring portion is worth significantly more per dollar of revenue because it's predictable, high-margin, and grows as the installed base grows.

Buyers will want a complete installed base register: every instrument, its location, installation date, service contract status, consumable run rate, and remaining useful life. A well-documented installed base is the single most important asset in this business. If your tracking is sloppy — if you can't tell a buyer exactly how many instruments are in the field, where they are, and what they're generating in recurring revenue — you'll leave money on the table.

Service Contracts and Recurring Revenue

Service contracts are where this business gets interesting from a valuation perspective. A maintenance agreement covering annual preventive maintenance, emergency repairs, and loaner instruments during downtime generates $2,000-$5,000 per instrument per year at 60-75% gross margins. If you have 400 instruments under contract, that's $800K-$2M in high-margin recurring revenue.

The key metrics buyers evaluate on service contracts:

• Attach rate: What percentage of your installed base has an active service contract? Top distributors achieve 70-85%. Below 50% signals that customers don't see enough value in your service offering.
• Renewal rate: Do contracts renew automatically? What's the annual retention rate? Above 90% is excellent. Below 80% suggests service quality issues or competitive pressure.
• Response time guarantees: Contracts with 4-hour or next-business-day response times in exchange for premium pricing demonstrate strong service capabilities and pricing power.

The EBITDA impact of a strong service contract book can be transformative. Equipment sales are lumpy and competitive on price. Service contracts are sticky and high-margin. A distributor doing 40% of revenue from service and consumables at 65% gross margin will command a higher EBITDA multiple than one doing 80% equipment sales at 25% gross margin, even if total revenue is similar.

What Drives Premium Multiples

Multi-line distribution. Carrying diagnostics from multiple manufacturers (in-clinic analyzers, reference lab equipment, digital imaging, ultrasound) makes you a one-stop shop for veterinary practices. Practices prefer fewer vendor relationships, and multi-line distributors have more cross-selling opportunities. This is worth 0.5-1.0x in additional multiple.

Proprietary training and support programs.If your team includes certified veterinary technicians who train practice staff on instrument operation, quality control, and result interpretation, you've built a value-added service layer that generic distributors can't match. This deepens customer relationships and increases switching costs.

Geographic density. A distributor with 200 instruments across a compact 100-mile radius can service them efficiently. A distributor with 200 instruments spread across 500 miles has higher travel costs, slower response times, and weaker customer relationships. Dense territories command higher valuations because the economics are better.

Growth in the installed base.If you've been adding 40-60 new instruments per year with 95% retention of existing accounts, your recurring revenue is compounding. Three years of consistent installed base growth is one of the strongest indicators a buyer can see.

What Kills Value in This Niche

Manufacturer direct competition.IDEXX has been expanding its direct sales force for years. If you're in a territory where the manufacturer is actively selling direct and your agreement doesn't protect you, buyers will question the longevity of your distribution economics. This is the single biggest structural risk in the business.

Technician dependency. If you have two field service engineers who know every instrument model and every client by name, and they leave after the sale, the business is crippled. Service businesses are people businesses, and buyers need confidence that your technicians will stay. Employment agreements with non-competes and retention bonuses are standard in these deals.

Declining consumable margins.If the manufacturer has been squeezing your margins on reagent cartridges over the last three years — moving from 30% distributor margin to 22% to 18% — that's a trend buyers will extrapolate forward. Demonstrate stable or growing margins, or explain why the compression has stopped.

Preparing for a Sale

Build your installed base register.Every instrument, every location, every contract, every consumable revenue stream — documented and current. This is your equivalent of a SaaS company's customer database.

Maximize your service contract attach rate. Every instrument in the field without a service contract is lost recurring revenue. Run a campaign to get lapsed customers back on contract. Even moving from 60% to 75% attach rate can add meaningful EBITDA and demonstrate to buyers that the opportunity for further improvement exists.

Clarify your distribution agreements. Get written confirmation from manufacturers on assignability, territory protection, and commission structures. A buyer will need to see these documents in due diligence, and ambiguity will slow or kill the deal.

Demonstrate the recurring revenue trajectory. Pull together a three-year view showing equipment sales, service contract revenue, and consumable revenue separately. Show the recurring revenue growing as a percentage of total revenue. This is the narrative that gets buyers excited and pushes multiples higher.

The Bottom Line

Veterinary diagnostic equipment distribution is a niche that rewards operators who think beyond the equipment sale. The hardware is just the entry point for a recurring revenue business built on service contracts, consumables, and deep customer relationships. Firms that have built large, well-documented installed bases with strong manufacturer agreements and high service contract attach rates will command the top of the 4-7x EBITDA range. Those still dependent on lumpy equipment sales with weak recurring revenue will trade at the bottom.